Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Title:
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Author:
Patnaik, Amita Gordon, Michael Tsai, Frank Papadopoulos, Kyriakos P. Rasco, Drew Beeram, Muralidhar Fu, Siqing Janku, Filip Hynes, Scott M. Gundala, Sushma R. Willard, Melinda D. Zhang, Wei Lin, Aimee Bence Hong, David